Skip to main content

Table 5 Result for change in flow rate (± 0.1)

From: Analytical method development and validation for simultaneous estimation of Fimasartan Potassium Trihydrate and Cilnidipine in synthetic mixture by HPLC for the treatment of hypertension stage-II

Flow rate (mL/min)

FIK

CLN

Mean area ± SD

RSD

Mean area ± SD

RSD

0.9

6,324,955 ± 5288.73

0.08

1,054,320 ± 1316.86

0.12

1.0

6,326,703 ± 4516.74

0.07

1,057,859 ± 1406.11

0.13

1.1

6,327,902 ± 5043.82

0.07

1,058,142 ± 1812.43

0.17